Literature DB >> 11799013

Development and validation of the International Knee Documentation Committee Subjective Knee Form.

Michael J Rossi, James H Lubowitz, Dan Guttmann.   

Abstract

Mesh：

Year:  2002        PMID： 11799013     DOI： 10.1177/03635465020300011301

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN： 0363-5465            Impact factor:   6.202


× No keyword cloud information.
  19 in total

1.  Neither significant osteoarthritic changes nor deteriorating subjective outcomes occur after hybrid fixation of osteochondritis dissecans in the young adult.

Authors:  L Chadli; C Steltzlen; P Beaufils; C Toanen; N Pujol
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-06-19       Impact factor: 4.342

2.  Hybrid fixation: evaluation of a novel technique in adult osteochondritis dissecans of the knee.

Authors:  Francois Lintz; Nicolas Pujol; Christophe Pandeirada; Philippe Boisrenoult; Philippe Beaufils
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-09-18       Impact factor: 4.342

3.  Females Have Earlier Muscle Strength and Functional Recovery After Bridge-Enhanced Anterior Cruciate Ligament Repair.

Authors:  Samuel Barnett; Gary J Badger; Ata Kiapour; Yi-Meng Yen; Rachael Henderson; Christina Freiberger; Benedikt Proffen; Nicholas Sant; Bethany Trainor; Braden C Fleming; Lyle J Micheli; Martha M Murray; Dennis E Kramer
Journal:  Tissue Eng Part A       Date:  2020-06-25       Impact factor: 3.845

4.  The prognosis and predictors of sports function and activity at minimum 6 years after anterior cruciate ligament reconstruction: a population cohort study.

Authors:  Kurt P Spindler; Laura J Huston; Rick W Wright; Christopher C Kaeding; Robert G Marx; Annunziato Amendola; Richard D Parker; Jack T Andrish; Emily K Reinke; Frank E Harrell; Warren R Dunn
Journal:  Am J Sports Med       Date:  2010-11-17       Impact factor: 6.202

5.  Objectively Measured Physical Activity in Patients After Anterior Cruciate Ligament Reconstruction.

Authors:  David R Bell; Karin A Pfeiffer; Lisa A Cadmus-Bertram; Stephanie M Trigsted; Adam Kelly; Eric G Post; Joseph M Hart; Dane B Cook; Warren R Dunn; Christopher Kuenze
Journal:  Am J Sports Med       Date:  2017-04-18       Impact factor: 6.202

6.  Ten-Year Outcomes and Risk Factors After Anterior Cruciate Ligament Reconstruction: A MOON Longitudinal Prospective Cohort Study.

Authors:  Kurt P Spindler; Laura J Huston; Kevin M Chagin; Michael W Kattan; Emily K Reinke; Annunziato Amendola; Jack T Andrish; Robert H Brophy; Charles L Cox; Warren R Dunn; David C Flanigan; Morgan H Jones; Christopher C Kaeding; Robert A Magnussen; Robert G Marx; Matthew J Matava; Eric C McCarty; Richard D Parker; Angela D Pedroza; Armando F Vidal; Michelle L Wolcott; Brian R Wolf; Rick W Wright
Journal:  Am J Sports Med       Date:  2018-03       Impact factor: 6.202

7.  Assessment of Free-Living Cadence Using ActiGraph Accelerometers Between Individuals With and Without Anterior Cruciate Ligament Reconstruction.

Authors:  Caroline M Lisee; Alexander H K Montoye; Noble F Lewallen; Mayrena Hernandez; David R Bell; Christopher M Kuenze
Journal:  J Athl Train       Date:  2020-09-01       Impact factor: 2.860

8.  Validity of the Genourob arthrometer in the evaluation of total thickness tears of anterior cruciate ligament.

Authors:  Anthony Saravia; Sebastián Cabrera; Claudio R Molina; Loreto Pacheco; Gabriel Muñoz
Journal:  J Orthop       Date:  2020-03-26

9.  Allogenic umbilical cord blood-derived mesenchymal stromal cell implantation was superior to bone marrow aspirate concentrate augmentation for cartilage regeneration despite similar clinical outcomes.

Authors:  Hong-Yeol Yang; Eun-Kyoo Song; Sung-Ju Kang; Woo-Kyoung Kwak; Joon-Kyoo Kang; Jong-Keun Seon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-01-25       Impact factor: 4.342

10.  Arthroscopic management of mucoid degeneration of anterior cruciate ligament.

Authors:  Chirag H Chudasama; Vyoma C Chudasama; Mukund M Prabhakar
Journal:  Indian J Orthop       Date:  2012-09       Impact factor: 1.251
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.